Table 1.
Ref. | Years | Study population | OBI |
Fukuda et al[52] | 1999 | 65 patients with HCV-related liver disease | 34/65 (52.3%) |
Kao et al[53] | 2002 | 210 patients with HCV-related liver disease | 31/210 (14.8%) |
Besisik et al[54] | 2003 | 33 HCV positive patients on hemodialysis | 12/33 (36.4%) |
Georgiadou et al[55] | 2004 | 187 patients with HCV-related liver disease | 49/187 |
Khattab et al[56] | 2005 | 53 patients with chronic HCV infection | 4/53 (7.5%) |
Goral et al[57] | 2006 | 50 HCV positive patients on hemodialysis | 0/50 |
Branco et al[43] | 2007 | 46 patients with HCV-related liver disease | 9/46 (19.5%) |
Toyoda et al[58] | 2007 | 95 HCV positive patients with HCC | 2/95 (2.1%) |
Shetty et al[59] | 2008 | 44 HCV positive patients with liver cirrhosis | 22/44 (50%) |
Tamori et al[60] | 2009 | 50 HCV positive patients with HCC | 21/50 (42%) |
Chen et al[61] | 2010 | 126 patients with chronic HCV infection | 6/126 (5%) |
Jang et al[62] | 2011 | 32 patients with chronic HCV infection | 9/32 (28.1%) |
Joukar et al[63] | 2012 | 59 HCV positive patients on hemodialysis | 0/59 |
Vakili Ghartavol et al[64] | 2013 | 50 patients with chronic HCV infection | 18/50(36%) |
Kishk et al[65] | 2014 | 162 patients with chronic HCV infection | 3/162 (1.85%) |
Mandour et al[66] | 2015 | 210 patients with chronic HCV infection | 53/210 (25.2%) |
HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus.